Top Markets
#1 B3 (Base) B3 (Base) +14.17%
#2 Janction Janction +12.47%
#3 DMT-NAT DMT-NAT +11.90%
#4 Fake World Assets Fake World Assets +11.22%
#5 TENDIES TENDIES +6.21%
#6 Status Status +4.85%
#7 GoPlus Security GoPlus Security +4.76%
#8 龙虾 (Lobster) 龙虾 (Lobster) +4.30%
#9 Provenance Blockchain Provenance Blockchain +3.88%
#10 Everything Everything +3.72%
Coin of the day
B3 (Base) B3 (Base)
Settings
Language
ENGLISH
Currency
USD
Theme
Qualis Innovations, Inc. Qualis Innovations, Inc.

Qualis Innovations, Inc.

QLIS
Rank in Stocks #34513
Qualis Innovations, Inc. (QLIS) specializes in the creation, manufacturing, and... Qualis Innovations, Inc. (QLIS) specializes in the creation, manufacturing, and distribution of solutions primarily targeting pain management and other disorders affecting the central nervous system (CNS). The company's flagship product is SOLACE, an advanced, non-invasive medical device. SOLACE functions by employing electromagnetic induction to produce therapeutic deep heat beneath the skin's surface, thereby alleviating and reducing pain. Qualis Innovations, Inc. maintains its corporate headquarters in Chadds Ford, Pennsylvania.
Share Price
$0.2667
Last synced: 2025-01-29
Market Cap
$5.45M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Qualis Innovations, Inc. (QLIS)

Category

Healthcare
P/E ratio for Qualis Innovations, Inc. (QLIS)
P/E ratio as of 2026 TTM: 0
According to Qualis Innovations, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Qualis Innovations, Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 35.77 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 34.86 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 20.90 -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 52.64 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.